2021-09-10 sec-litreleases litigation_release 65 KB 1,520 chars

SEC v. Mark Ahn, No. LR-25202, District of Massachusetts (Sept. 10, 2021) — Press Release

raw: Mark Ahn

Mark Ahn, No. 1:21-cv-10203 (Sept. 10, 2021)

Caption
Securities & Exchange Commission v. Ahn
Source PDF JSON
summary

Mark Ahn, former consultant and board member, committed insider trading in Dimension Therapeutics' securities ahead of its 2017 merger announcement and was sentenced to prison, fined, and barred from serving as an officer or director.

paragraph

Mark Ahn was charged with violating Section 10(b) of the Securities Exchange Act and Rule 10b-5 for insider trading in Dimension Therapeutics' securities ahead of its August 2017 merger announcement. Ahn was sentenced to six months in prison, fined $5,500, and ordered to forfeit $49,421. The SEC's action against Ahn concluded with a final judgment on September 8, 2021, after Ahn was barred from serving as an officer or director of any SEC reporting company.

narrative

Mark Ahn, a former consultant and board member of Dimension Therapeutics, Inc., engaged in insider trading in the company's securities ahead of its August 2017 merger announcement. The SEC alleged that Ahn violated Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. Ahn was charged with antifraud provisions and ultimately agreed to a final judgment. In a parallel criminal case, Ahn pleaded guilty on March 2, 2021, and was sentenced on June 7, 2021, to six months in prison, six months of home detention, two years of supervised release, a fine of $5,500, forfeiture of $49,421, and restitution to be determined later. The court previously entered a partial judgment enjoining Ahn from violating the statutes and barring him from serving as an officer or director of any SEC reporting company. The SEC's civil action against Ahn concluded with the final judgment entered on September 8, 2021.

Enriched metadata

Scheme
insider-trading (99%)
Court
District of Massachusetts
Case No.
1:21-cv-10203
Outcome
pleaded · 2021-03-02
Civil penalty
$49,421
Entity
Mark Ahn
Classified insider-trading(confidence 99%). EDGAR detection: forms 4/3/5/144· recall 81% / precision 19%. detection rule →
Statutes
Section 10(b) of the Securities Exchange ActRule 10b-5
Parties
Securities & Exchange CommissionMark J Ahn
Keywords
ahnfinal againstsecurities exchangemarksecuritiesinsider tradingexchange commissionfinalagainstseptemberexchangeactionsecinsidertrading

Exhibits & Attached Documents (1)

Extracted insights

Dollar amounts 2
  • $49K $49,421 $10K–$100K
  • $6K $5,500 <$10K
Entities 8
  • person against mark ahn
  • company dimension therapeutics, inc.
  • person final judgment
  • scheme_term insider trading
  • person mark ahn
  • company merger of dimension therapeutics, inc.
  • agency Securities and Exchange Commission
  • company securities of dimension therapeutics, inc.
Triples 53
  • SEC obtains final judgment
  • SEC announced it obtained a final judgment against Oregon resident Mark Ahn
  • Mark Ahn engaged in insider trading
  • Mark Ahn charged with insider trading
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • SEC obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading
  • Mark Ahn traded in securities of Dimension Therapeutics, Inc.
  • SEC filed action against Mark Ahn
  • SEC announced merger of Dimension Therapeutics, Inc.
  • SEC obtained final judgment
  • SEC announced it obtained a final judgment against Oregon resident Mark Ahn
  • SEC alleged Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc.
  • SEC filed a previously-filed action
  • Mark Ahn engaged in insider trading
  • Ahn trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc.
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained a final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained a final judgment against Mark Ahn on September 8, 2021
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained a final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained a final judgment against Mark Ahn
  • Mark Ahn engaged in insider trading
  • Mark Ahn charged with insider trading
  • SEC obtained final judgment against Mark Ahn
  • SEC announced final judgment on September 8, 2021
  • Mark Ahn allegedly traded securities of Dimension Therapeutics, Inc.
  • Dimension Therapeutics, Inc. announced merger in August 2017
  • SEC filed action on February 5, 2021
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
  • SEC obtained final judgment against Former Consultant and Board Member Charged with Insider Trading
  • SEC announced it obtained a final judgment against Oregon resident Mark Ahn on September 8, 2021 in a previously-filed action alleging that Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement.
  • SEC alleged Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement.
  • Mark Ahn engaged in insider trading in the securities of Dimension Therapeutics, Inc. in advance of an August 2017 merger announcement
  • Securities and Exchange Commission obtained final judgment against Mark Ahn
PDF (from attached: judgment)
SEC v. MARK J. AHN · Source
Text layers
Extracted body text (1,520c) 
SEC Obtains Final Judgment Against Former Consultant and Board Member Charged with Insider Trading Litigation Release No. 25202 / September 10, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) The Securities and Exchange Commission announced that it obtained a final judgment against Oregon resident Mark Ahn on September 8, 2021 in a previously-filed action alleging that Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement. The SEC's complaint, filed on February 5, 2021 in the United States District Court for the District of Massachusetts, charged Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. On April 28, 2021, the court entered a partial judgment that enjoins Ahn from violating the above statutes and bars him from serving as an officer or director of any SEC reporting company. The court's September 8, 2021 entry of the final judgment against Ahn marks the conclusion of the SEC's action. In a parallel criminal action brought by the U.S. Attorney's Office for the District of Massachusetts, Ahn pleaded guilty on March 2, 2021 and was sentenced on June 7, 2021 to six months in prison, six months of home detention, two years of supervised release, a fine of $5,500, forfeiture of $49,421 and restitution to be determined at a later date. Judgment
OCR text (1,520c · html-text · 99% conf) 
SEC Obtains Final Judgment Against Former Consultant and Board Member Charged with Insider Trading Litigation Release No. 25202 / September 10, 2021 Securities and Exchange Commission v. Mark Ahn, No. 1:21-cv-10203 (D. Mass. filed February 5, 2021) The Securities and Exchange Commission announced that it obtained a final judgment against Oregon resident Mark Ahn on September 8, 2021 in a previously-filed action alleging that Ahn engaged in insider trading in the securities of a Massachusetts-based pharmaceutical company, Dimension Therapeutics, Inc., in advance of an August 2017 merger announcement. The SEC's complaint, filed on February 5, 2021 in the United States District Court for the District of Massachusetts, charged Ahn with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. On April 28, 2021, the court entered a partial judgment that enjoins Ahn from violating the above statutes and bars him from serving as an officer or director of any SEC reporting company. The court's September 8, 2021 entry of the final judgment against Ahn marks the conclusion of the SEC's action. In a parallel criminal action brought by the U.S. Attorney's Office for the District of Massachusetts, Ahn pleaded guilty on March 2, 2021 and was sentenced on June 7, 2021 to six months in prison, six months of home detention, two years of supervised release, a fine of $5,500, forfeiture of $49,421 and restitution to be determined at a later date. Judgment

Related documents (1)